nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—hindbrain—amyotrophic lateral sclerosis	0.0633	0.374	CbGeAlD
Degarelix—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.0558	0.0672	CcSEcCtD
Degarelix—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.05	0.0601	CcSEcCtD
Degarelix—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0407	0.049	CcSEcCtD
Degarelix—GNRHR—brainstem—amyotrophic lateral sclerosis	0.0363	0.214	CbGeAlD
Degarelix—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.0276	0.0333	CcSEcCtD
Degarelix—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.0273	0.0329	CcSEcCtD
Degarelix—Abscess—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0236	CcSEcCtD
Degarelix—GNRHR—nervous system—amyotrophic lateral sclerosis	0.019	0.112	CbGeAlD
Degarelix—GNRHR—central nervous system—amyotrophic lateral sclerosis	0.0183	0.108	CbGeAlD
Degarelix—GNRHR—cerebellum—amyotrophic lateral sclerosis	0.0179	0.106	CbGeAlD
Degarelix—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0214	CcSEcCtD
Degarelix—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0208	CcSEcCtD
Degarelix—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0206	CcSEcCtD
Degarelix—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0167	0.0201	CcSEcCtD
Degarelix—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0197	CcSEcCtD
Degarelix—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0186	CcSEcCtD
Degarelix—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0185	CcSEcCtD
Degarelix—GNRHR—brain—amyotrophic lateral sclerosis	0.0145	0.0858	CbGeAlD
Degarelix—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0162	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0156	CcSEcCtD
Degarelix—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0156	CcSEcCtD
Degarelix—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0146	CcSEcCtD
Degarelix—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0143	CcSEcCtD
Degarelix—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0139	CcSEcCtD
Degarelix—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0134	CcSEcCtD
Degarelix—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0122	CcSEcCtD
Degarelix—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00992	0.0119	CcSEcCtD
Degarelix—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00932	0.0112	CcSEcCtD
Degarelix—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00909	0.0109	CcSEcCtD
Degarelix—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00898	0.0108	CcSEcCtD
Degarelix—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00895	0.0108	CcSEcCtD
Degarelix—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00884	0.0106	CcSEcCtD
Degarelix—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00879	0.0106	CcSEcCtD
Degarelix—Depression—Riluzole—amyotrophic lateral sclerosis	0.00864	0.0104	CcSEcCtD
Degarelix—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00854	0.0103	CcSEcCtD
Degarelix—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00849	0.0102	CcSEcCtD
Degarelix—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00842	0.0101	CcSEcCtD
Degarelix—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00819	0.00986	CcSEcCtD
Degarelix—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00774	0.00932	CcSEcCtD
Degarelix—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00768	0.00925	CcSEcCtD
Degarelix—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00766	0.00922	CcSEcCtD
Degarelix—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00762	0.00918	CcSEcCtD
Degarelix—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00727	0.00875	CcSEcCtD
Degarelix—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00722	0.00869	CcSEcCtD
Degarelix—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00706	0.00849	CcSEcCtD
Degarelix—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00703	0.00846	CcSEcCtD
Degarelix—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00844	CcSEcCtD
Degarelix—Chills—Riluzole—amyotrophic lateral sclerosis	0.00698	0.0084	CcSEcCtD
Degarelix—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00695	0.00836	CcSEcCtD
Degarelix—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00687	0.00827	CcSEcCtD
Degarelix—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00681	0.0082	CcSEcCtD
Degarelix—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00677	0.00815	CcSEcCtD
Degarelix—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00655	0.00788	CcSEcCtD
Degarelix—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00651	0.00784	CcSEcCtD
Degarelix—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00628	0.00756	CcSEcCtD
Degarelix—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00626	0.00753	CcSEcCtD
Degarelix—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00611	0.00735	CcSEcCtD
Degarelix—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00598	0.0072	CcSEcCtD
Degarelix—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00585	0.00704	CcSEcCtD
Degarelix—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00576	0.00694	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00689	CcSEcCtD
Degarelix—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0057	0.00686	CcSEcCtD
Degarelix—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00564	0.00679	CcSEcCtD
Degarelix—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00553	0.00665	CcSEcCtD
Degarelix—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00652	CcSEcCtD
Degarelix—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00537	0.00646	CcSEcCtD
Degarelix—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00643	CcSEcCtD
Degarelix—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00516	0.00622	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00606	CcSEcCtD
Degarelix—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.005	0.00602	CcSEcCtD
Degarelix—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00593	CcSEcCtD
Degarelix—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0048	0.00578	CcSEcCtD
Degarelix—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00477	0.00574	CcSEcCtD
Degarelix—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00573	CcSEcCtD
Degarelix—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00569	CcSEcCtD
Degarelix—Pain—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00569	CcSEcCtD
Degarelix—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00548	CcSEcCtD
Degarelix—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00452	0.00544	CcSEcCtD
Degarelix—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00528	CcSEcCtD
Degarelix—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00526	CcSEcCtD
Degarelix—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00526	CcSEcCtD
Degarelix—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0049	CcSEcCtD
Degarelix—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00396	0.00477	CcSEcCtD
Degarelix—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00471	CcSEcCtD
Degarelix—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00455	CcSEcCtD
Degarelix—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0044	CcSEcCtD
Degarelix—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00423	CcSEcCtD
Degarelix—Rash—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00419	CcSEcCtD
Degarelix—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00419	CcSEcCtD
Degarelix—Headache—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00417	CcSEcCtD
Degarelix—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00395	CcSEcCtD
